Brief: NanoEcho PoC Study Does Not Meet Primary Endpoint
17/06/2026 11:28
BRIEF-NanoEcho PoC Study Does Not Meet Primary Endpoint June 17 (Reuters) - NanoEcho AB (publ) NANECH.ST:
ANNOUNCES RESULTS FROM INITIAL PART OF EXPLORATORY PROOF OF CONCEPT (POC) STUDY IN HEALTHY STUDY PARTICIPANTS
STUDY DID NOT ACHIEVE PRIMARY ENDPOINT
PRIMARY ENDPOINT WAS TO VALIDATE PREVIOUSLY ESTABLISHED DOSE OF NANOPARTICLE NEP-01, TIMING OF EXAMINATION WITH CO'S DIAGNOSTIC SYSTEM
NO SERIOUS ADVERSE EFFECTS HAVE BEEN REPORTED DURING STUDY
BASED ON RESULTS, CO TO EVALUATE WHETHER ANY ADJUSTMENTS TO DIAGNOSTIC SYSTEM, METHOD MAY BE RELEVANT FOR NEXT PART OF POC STUDY
Further company coverage: NANECH.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))